These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 13685504)

  • 21. Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana).
    Maslow JN; Mikota SK; Zhu M; Isaza R; Peddie LR; Dunker F; Peddie J; Riddle H; Peloquin CA
    J Vet Pharmacol Ther; 2005 Feb; 28(1):21-7. PubMed ID: 15720511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of rifampicin and pyrazinamide on isoniazid pharmacokinetics in rats.
    Baldan HM; De Rosa HJ; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Nov; 28(8):409-13. PubMed ID: 17828712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
    Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
    J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress potentiated by diallylsulfide, a selective CYP2E1 inhibitor, in isoniazid toxic effect on rat primary hepatocytes.
    Zhai Q; Lu SR; Lin Y; Yang QL; Yu B
    Toxicol Lett; 2008 Dec; 183(1-3):95-8. PubMed ID: 18992798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
    Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
    Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of gene chip in detecting Mycobacterium tuberculosis resistant to rifampin and isoniazid].
    Cui ZL; Jing FX; Hu ZY; Wu ZR; Zhao JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):439-41. PubMed ID: 15312553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
    De Rosa HJ; Baldan HM; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Sep; 28(6):291-6. PubMed ID: 17571294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
    Alaei K; Alaei A; Mansouri D
    East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies of INH-on the role of INH in combination with SM, PAS, and INH with special reference to the role of INH].
    OKA S
    Kekkaku; 1961 Aug; 36():512-20. PubMed ID: 13730558
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the use of vitamin B6 in the field of INH therapy].
    IRSKENS KJ
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 123():80-9. PubMed ID: 13717890
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experiences with the treatment of pulmonary tuberculosis with INH--ultrasonic aerosols].
    PICKROTH G
    Dtsch Gesundheitsw; 1960 Aug; 15():1668-73. PubMed ID: 13735486
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of lupus vulgaris with INH, PAS, and Tebamine.
    WEHNERT RA; MARCUSSEN PV
    Acta Derm Venereol; 1961; 41():461-70. PubMed ID: 14005585
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical studies of INH].
    BABA T
    Kekkaku; 1961 Aug; 36():508-11. PubMed ID: 13685504
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.